1245634-25-6
Chemical Structure
Actoxumab
Synonym(s): Anti-C. difficile Toxin A Recombinant Antibody
- CAS No.: 1245634-25-6
- Formula:N/A
- Molecular Weight:(145 kDa)
IUPAC Name: 3-((2-chlorophenyl)amino)-2-cyano-3-thioxo-N-(3-(trifluoromethyl)phenyl)propanamide
SMILES: [Actoxumab]
Biological Activity: Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Actoxumab | 99.52% | Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab (HY-P9929) targeting TcdB. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
